Family · Pharmaceutical analytical standards
Duloxetine
An SNRI antidepressant that boosts serotonin and noradrenaline, approved in the United States in 2004 for major depression and, a month later, for diabetic neuropathic pain. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?In Europe it has also been authorised since 2004 for stress urinary incontinence in women, an indication never approved in the United States.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
